409 Trial in progress: a phase 2 study to assess the safety, efficacy of FLX475 combined with pembrolizumab in patients with advanced or metastatic gastric cancer

• Do-Youn Oh,
• Jeeyun Lee,
• Keun-Wook Lee,
• Hyun Cheol Chung,
• Michael Chisamore,
• Paul Rhee,
• Taewan Kim,
• Sang Cheul Oh,
• Min Hee Ryu,
• Jun-Eul Hwang,
• Jaeyong Cho,
• Dae Young Zang,
• Byoung Yong Shim,
• William Ho,
• Ji Yeong Won,
• Eunhye Baek,
• SeungJae Baek

Affiliations

Do-Youn Oh

1Seoul National University Hospital, Seoul, Korea, Republic of

Jeeyun Lee

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

Keun-Wook Lee

Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, South Korea

Hyun Cheol Chung

Yonsei Cancer Center, Songdang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea

Michael Chisamore

2Merch and Co., Inc., Rahway, NJ, USA

Paul Rhee

Calhoun Vision, Inc., Pasadena, California, USA

Taewan Kim

Department of Surgery, SUNY Upstate Medical University, Syracuse, New York, USA

Sang Cheul Oh

Department of Systems Biology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Min Hee Ryu

2University of Ulsan College of Medicine, Seoul, Korea, Republic of

Jun-Eul Hwang

3Chonnam National University Medical School, Gwangju, Korea, Republic of

Jaeyong Cho

4Yonsei University College of Medicine, Seoul, Korea, Republic of

Dae Young Zang

5Hallym University College of Medicine, Anyang, Korea, Republic of

Byoung Yong Shim

8The Catholic University of Korea, Suwon, Korea, Republic of

William Ho

10RAPT Therapeutics, South San Francisco, CA, USA

Ji Yeong Won

11Hanmi Pharmaceutical Co., Ltd., Seoul, Korea, Republic of

Eunhye Baek

11Hanmi Pharmaceutical Co., Ltd., Seoul, Korea, Republic of

SeungJae Baek

11Hanmi Pharmaceutical Co., Ltd., Seoul, Korea, Republic of